Submitted Successfully!
To reward your contribution, here is a gift for you: A free trial for our video production service.
Thank you for your contribution! You can also upload a video entry or images related to this topic.
Version Summary Created by Modification Content Size Created at Operation
1 + 557 word(s) 557 2020-12-15 07:36:34

Video Upload Options

Do you have a full video?

Confirm

Are you sure to Delete?
Cite
If you have any further questions, please contact Encyclopedia Editorial Office.
Tang, N. Pyruvate Kinase Deficiency. Encyclopedia. Available online: https://encyclopedia.pub/entry/4825 (accessed on 19 June 2024).
Tang N. Pyruvate Kinase Deficiency. Encyclopedia. Available at: https://encyclopedia.pub/entry/4825. Accessed June 19, 2024.
Tang, Nora. "Pyruvate Kinase Deficiency" Encyclopedia, https://encyclopedia.pub/entry/4825 (accessed June 19, 2024).
Tang, N. (2020, December 24). Pyruvate Kinase Deficiency. In Encyclopedia. https://encyclopedia.pub/entry/4825
Tang, Nora. "Pyruvate Kinase Deficiency." Encyclopedia. Web. 24 December, 2020.
Pyruvate Kinase Deficiency
Edit

Pyruvate kinase deficiency is an inherited disorder that affects red blood cells, which carry oxygen to the body's tissues.

genetic conditions

1.  Introduction

People with this disorder have a condition known as chronic hemolytic anemia, in which red blood cells are broken down (undergo hemolysis) prematurely, resulting in a shortage of red blood cells (anemia). Specifically, pyruvate kinase deficiency is a common cause of a type of inherited hemolytic anemia called hereditary nonspherocytic hemolytic anemia. In hereditary nonspherocytic hemolytic anemia, the red blood cells do not assume a spherical shape as they do in some other forms of hemolytic anemia.

Chronic hemolytic anemia can lead to unusually pale skin (pallor), yellowing of the eyes and skin (jaundice), extreme tiredness (fatigue), shortness of breath (dyspnea), and a rapid heart rate (tachycardia). An enlarged spleen (splenomegaly), an excess of iron in the blood, and small pebble-like deposits in the gallbladder or bile ducts (gallstones) are also common in this disorder.

In people with pyruvate kinase deficiency, hemolytic anemia and associated complications may range from mild to severe. Some affected individuals have few or no symptoms. Severe cases can be life-threatening in infancy, and such affected individuals may require regular blood transfusions to survive. The symptoms of this disorder may get worse during an infection or pregnancy.

2. Frequency

Pyruvate kinase deficiency is the most common inherited cause of nonspherocytic hemolytic anemia. More than 500 affected families have been identified, and studies suggest that the disorder may be underdiagnosed because mild cases may not be identified.

Pyruvate kinase deficiency is found in all ethnic groups. Its prevalence has been estimated at 1 in 20,000 people of European descent. It is more common in the Old Order Amish population of Pennsylvania.

3. Causes

Pyruvate kinase deficiency is caused by mutations in the PKLR gene. The PKLR gene is active in the liver and in red blood cells, where it provides instructions for making an enzyme called pyruvate kinase. The pyruvate kinase enzyme is involved in a critical energy-producing process known as glycolysis. During glycolysis, the simple sugar glucose is broken down to produce adenosine triphosphate (ATP), the cell's main energy source.

PKLR gene mutations result in reduced pyruvate kinase enzyme function, causing a shortage of ATP in red blood cells and increased levels of other molecules produced earlier in the glycolysis process. The abnormal red blood cells are gathered up by the spleen and destroyed, causing hemolytic anemia and an enlarged spleen. A shortage of red blood cells to carry oxygen throughout the body leads to fatigue, pallor, and shortness of breath. Iron and a molecule called bilirubin are released when red blood cells are destroyed, resulting in an excess of these substances circulating in the blood. Excess bilirubin in the blood causes jaundice and increases the risk of developing gallstones.

Pyruvate kinase deficiency may also occur as an effect of other blood diseases, such as leukemia. These cases are called secondary pyruvate kinase deficiency and are not inherited.

4. Inheritance

This condition is inherited in an autosomal recessive pattern, which means both copies of the gene in each cell have mutations. The parents of an individual with an autosomal recessive condition each carry one copy of the mutated gene, but they typically do not show signs and symptoms of the condition.

5. Other Names for This Condition

  • PK deficiency

  • PKD

References

  1. Ayi K, Min-Oo G, Serghides L, Crockett M, Kirby-Allen M, Quirt I, Gros P, KainKC. Pyruvate kinase deficiency and malaria. N Engl J Med. 2008 Apr24;358(17):1805-10. doi: 10.1056/NEJMoa072464.
  2. Beutler E, Gelbart T. Estimating the prevalence of pyruvate kinase deficiency from the gene frequency in the general white population. Blood. 2000 Jun1;95(11):3585-8.
  3. Climent F, Roset F, Repiso A, Pérez de la Ossa P. Red cell glycolytic enzymedisorders caused by mutations: an update. Cardiovasc Hematol Disord Drug Targets.2009 Jun;9(2):95-106. Review.
  4. Durand PM, Coetzer TL. Pyruvate kinase deficiency protects against malaria in humans. Haematologica. 2008 Jun;93(6):939-40. doi: 10.3324/haematol.12450.
  5. Rider NL, Strauss KA, Brown K, Finkenstedt A, Puffenberger EG, Hendrickson CL,Robinson DL, Muenke N, Tselepis C, Saunders L, Zoller H, Morton DH. Erythrocytepyruvate kinase deficiency in an old-order Amish cohort: longitudinal risk anddisease management. Am J Hematol. 2011 Oct;86(10):827-34. doi: 10.1002/ajh.22118.
  6. van Wijk R, Huizinga EG, van Wesel AC, van Oirschot BA, Hadders MA, vanSolinge WW. Fifteen novel mutations in PKLR associated with pyruvate kinase (PK) deficiency: structural implications of amino acid substitutions in PK. Hum Mutat.2009 Mar;30(3):446-53. doi: 10.1002/humu.20915.
  7. van Wijk R, van Solinge WW. The energy-less red blood cell is lost:erythrocyte enzyme abnormalities of glycolysis. Blood. 2005 Dec15;106(13):4034-42.
  8. Zanella A, Fermo E, Bianchi P, Chiarelli LR, Valentini G. Pyruvate kinasedeficiency: the genotype-phenotype association. Blood Rev. 2007 Jul;21(4):217-31.
  9. Zanella A, Fermo E, Bianchi P, Valentini G. Red cell pyruvate kinasedeficiency: molecular and clinical aspects. Br J Haematol. 2005 Jul;130(1):11-25.Review.
More
Information
Contributor MDPI registered users' name will be linked to their SciProfiles pages. To register with us, please refer to https://encyclopedia.pub/register :
View Times: 399
Entry Collection: MedlinePlus
Revision: 1 time (View History)
Update Date: 23 Mar 2021
1000/1000
Video Production Service